A strategic and technical advisory committee to the Consortium Executive Committee, the Advisory Committee provides counsel on new initiatives, health science or health policy issues, and other activities of the consortium.
Consortium members may participate in working committees. Please contact us.
Asia Consortium Advisory Committee Members (2017-2019)
2017-2019 Chair
Bruce Crawford, MPH, MA
Vice President, Real World Evidence & Insights, inVentiv Health Japan G.K., Tokyo, Japan
2017-2019 Chair-Elect
Chee-Jen Chang, PhD
Director, Clinical Informatics and Medical Statistics Research Center and Professor, Graduate Institute of Clinical Medical Sciences, Chang Gung University, TaoYuan, Taiwan
Jeonghoon Ahn, PhD, MA
Associate Professor, Department of Health Convergence, EWHA Womans University, Seoul, South Korea
SeungJin Bae, Sc.D., R.Ph
Associate Professor, Ewha Womens University, College of Pharmacy, Seoul, South Korea
Nathorn Chaiyakunapruk, Pharm.D., PhD
Professor of Health Economics, School of Pharmacy, Monash University Malaysia, Selangor, Malaysia
Ruoyan Gai, MSc, PhD
Chief, Division of Policy Evaluation, Department of Health Policy, and Chief, Division of Health Technology Assessment, Department of Clinical Epidemiology, National Center for Child Health and Development, Tokyo, Japan
Alex Z. Fu, PhD
Associate Professor, Department of Oncology, Georgetown University Medical Center, Washington, DC, USA
Allen Lai, PhD, MD, MSc
Regional Managing Director, ACT Genomics, Singapore
Jeff J. Guo, BPharm, PhD
Professor, Pharmacy Practice & Administrative Sciences, University of Cincinnati College of Pharmacy, Cincinnati, Ohio, USA
Kenneth KC Lee, BSc(Pharm), MPhil, PhD, Reg Pharm (HK)
Professor of Pharmacy, School of Pharmacy, Monash University, Selangor, Malaysia
Eui-Kyung Lee, PhD, RPh
Professor, SungKyunKwan University (SKKU), Seoul, South Korea
Shu Chuen Li, MApplSc, MBA, PhD
Chair Professor of Pharmacy & Head of Pharmacy and Experimental Pharmacology, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia
Vivian WY Lee, BSc, PharmD, BCPS (Added Qualification in Cardiology)
Associate Professor, School of Pharmacy, and Assistant Dean (Student Development), Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
Xin Sun, PhD
Professor and Director, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China
Hong Li, PhD, MPH
Lead, Trans-Pacific Outcomes Research (TOR) LLC, USA
Jing Wu, PHD
Professor, Pharmaceutical Economics and Policy, Tianjin University, Tianjin, China
Surachat Ngorsuraches, PhD
Associate Professor, College of Pharmacy and Allied Health Professions, South Dakota State University, Brookings, South Dakota, USA
Ming-Chin Yang, PhD
Professor, Institute of Health Policy and Management, National Taiwan University, Taipei, Taiwan
Jennifer C. Sung, PharmD, MS, MBA
Head, Cardiovascular HE&OR, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
Mingliang Zhang, PhD
Senior Director, Design and Analytics, Real World Evidence Janssen Scientific Affairs, Titusville, NJ, USA
Jianwei Xuan MD, PhD
Professor and Director, Health Economic Research Institute, Sun Yat-sen University, Guangzhou, China